Showing posts with label steroid hormone. Show all posts
Showing posts with label steroid hormone. Show all posts

Monday, 4 October 2010

Contraceptive pills effective for controlling severe premenstrual disorder

According to a recently concluded study, a low dose of oral contraceptive shows as much efficacy as the standard treatment for the most severe form of premenstrual syndrome, premenstrual dysphoric disorder (PMDD).
Kimberly Yonkers, M.D., associate professor in the departments of Psychiatry and Epidemiology and Public Health and lead author of the study, remarked that individuals with this complication generally cyclical mood, behavioral and physical symptoms.
In this multi-center, double-blind, randomized clinical trial, 450 women ages 18 to 40, from 64 medical centers across the country with symptoms of PMDD, were given either the oral contraceptive or a placebo.
It was found that the women who were given the oral contraceptive had significantly greater improvement, over 48 percent compared to 36 percent, of women on the placebo.
They experienced greater enjoyment of hobbies, social activities, and interpersonal relationships, and greater symptom reduction.
It seems that forty-four women from both groups withdrew from the study due to adverse effects such as nausea and intermenstrual bleeding.
The low dose oral contraceptive contained drospirenone, a new progestin, and ethinyl estradiol.
In the study it was taken for 24 days followed by four days of inactive pills, which differs from traditional courses of therapy which have seven days of inactive pills.
It was remarked by researchers at Yale School of Medicine that a low dose of oral contraceptive with a unique progestin and dosing regimen is good enough for treating PMDD along with suppressing ovarian activity.

Wednesday, 10 February 2010

Performance of city traders positively stimulated by hormone levels


According to a study, naturally produced steroids in the body, especially cortisol and testosterone, has the positive effect of influencing performance of city traders to a significant extent.
It was noted that high morning testosterone levels may help traders to earn more than just average profits, as per a research conducted at the University of Cambridge.
It was hypothesized that this performance improvement can be because testosterone is acclaimed for improving the appetite for confidence and risk - factors that can easily augment performance of financial traders.
The researchers also speculated that if testosterone continued to rise or became chronically elevated, it could begin to have the opposite effect on a trader's profitability by increasing risk-taking to unprofitable levels. Previous studies have shown that administered testosterone can lead to irrational decision-making. They believe that this is because testosterone has also been found to lead to impulsivity and sensation seeking, to harmful risk taking, and in extreme cases (among users of anabolic steroids) to euphoria and mania.
Testosterone may therefore underlie a secondary consequence of the ‘winner effect' in which a previous win in the markets leads to increased, and eventually irrational, risk taking in the next round of trading.
It was also noted that this finding can also help in ascertaining how and why people caught in crashes often find it tedious to make a rational decision.

Sunday, 23 August 2009

Untold relationship between financial traders and hormone levels

As per a recently concluded research by Israeli researchers, City Traders tend to gain more when it comes to average profits in the morning times when testosterone levels are high.

It was hypothesized by the involved scientists that the positive return for traders is simply because testosterone is believed to raise the level of confidence apart from raising the appetite for risk.

Testosterone is a steroid hormone that plays an important role in competitive encounters and sexual behavior. The 'winner effect', which is possible with testosterone, offers a unique ability to raise the chances of winning and winning on a repeated basis.

From News-Medical.Net:
In order to determine how hormone levels affect those working in the financial sector, the researchers followed 17 City of London male traders for eight consecutive business days. To measure the traders' hormones, they took saliva samples twice per day at 11:00 a.m. and 4:00 p.m., times that fell before and after the bulk of the day's trading. At each sampling time, traders recorded their profit and loss (P&L).

Using the trader's previous trading history, the scientists determined a daily-average to which they could compare the test results. They found that daily testosterone levels were significantly higher on days when traders made more than their one-month daily average than on other days.

The researchers also speculated that if testosterone continued to rise or became chronically elevated, it could begin to have the opposite effect on a trader's profitability by increasing risk-taking to unprofitable levels. Previous studies have shown that administered testosterone can lead to irrational decision-making. They believe that this is because testosterone has also been found to lead to impulsivity and sensation seeking, to harmful risk taking, and in extreme cases (among users of anabolic steroids) to euphoria and mania.
Dr. John Coates, lead author, remarked that the raised levels of testosterone and cortisol allow traders to take business risks. However, there may be addiction if the level of testosterone reaches physiological limits.